HomeCompareNBGIF vs MRK

NBGIF vs MRK: Dividend Comparison 2026

NBGIF yields 4.76% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $29.4K in total portfolio value
10 years
NBGIF
NBGIF
● Live price
4.76%
Share price
$16.02
Annual div
$0.76
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$27.3K
Annual income
$645.85
Full NBGIF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — NBGIF vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNBGIFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NBGIF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NBGIF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NBGIF
Annual income on $10K today (after 15% tax)
$404.73/yr
After 10yr DRIP, annual income (after tax)
$548.97/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $7,779.44/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NBGIF + MRK for your $10,000?

NBGIF: 50%MRK: 50%
100% MRK50/50100% NBGIF
Portfolio after 10yr
$42.1K
Annual income
$5,222.00/yr
Blended yield
12.42%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

NBGIF
Analyst Ratings
2
Buy
1
Hold
Consensus: Buy
Altman Z
0.3
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NBGIF buys
0
MRK buys
0
No recent congressional trades found for NBGIF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNBGIFMRK
Forward yield4.76%2.76%
Annual dividend / share$0.76$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$27.3K$56.8K
Annual income after 10y$645.85$9,798.13
Total dividends collected$5.6K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: NBGIF vs MRK ($10,000, DRIP)

YearNBGIF PortfolioNBGIF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,176$476.15$11,206$366.19$30.00MRK
2$12,456$497.34$12,650$502.35$194.00MRK
3$13,846$518.02$14,407$694.19$561.00MRK
4$15,353$538.16$16,585$967.82$1.2KMRK
5$16,986$557.70$19,342$1,363.89$2.4KMRK
6$18,751$576.64$22,913$1,947.19$4.2KMRK
7$20,659$594.93$27,662$2,823.89$7.0KMRK
8$22,717$612.57$34,159$4,173.35$11.4KMRK
9$24,937$629.55$43,337$6,308.80$18.4KMRK
10$27,329$645.85$56,776$9,798.13$29.4KMRK

NBGIF vs MRK: Complete Analysis 2026

NBGIFStock

National Bank of Greece S.A., together with its subsidiaries, provides financial products and services in Greece, the United Kingdom, North Macedonia, Romania, Cyprus, Bulgaria, Malta, Egypt, and Luxembourg. The company operates through Retail Banking, Corporate & Investment Banking, Trouble Assets Unit, Global Markets and Asset Management, Insurance, International Banking Operations, and Other segments. The Retail Banking segment provides deposit, investment, bancassurance products, mortgage loans, consumer and small business lending, debit and credit cards, prepaid cards, and other traditional products and services for individual customers, professionals, and small-medium and small sized companies through its network of branches and digital businesses. The Corporate & Investment Banking segment offers financial and investment advisory services, deposit accounts, loans, foreign exchange, and trade services for corporate customers; and lending services for large and medium-sized companies, as well as shipping finance services. The Trouble Assets Unit segment manages various loans. The Global Markets and Asset Management segment is involved in treasury activities; and provision of asset management, custody, private equity, and brokerage services. The Insurance offers various insurance products. The International Banking Operations segment offers traditional commercial banking, such as commercial and retail credit, trade financing, foreign exchange, and deposits; shipping finance; investment banking; and brokerage services through its foreign branches. The Other segment engages in the real estate management and warehousing businesses. As of December 31, 2021, the company operates 337 branches, 16 Transaction Offices, 2 I-Bank Stores, and 1,474 ATMs in Greece. National Bank of Greece S.A. was founded in 1841 and is headquartered in Athens, Greece.

Full NBGIF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this NBGIF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NBGIF vs SCHDNBGIF vs JEPINBGIF vs ONBGIF vs KONBGIF vs MAINNBGIF vs JNJNBGIF vs ABBVNBGIF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.